Antenatal corticosteroid treatment: what's happened since Drs Liggins and Howie?

      In 1972, Drs Liggins and Howie published a landmark article demonstrating that antenatal corticosteroids significantly reduced the frequency of respiratory distress syndrome and neonatal mortality. A single course of antenatal corticosteroids has become standard of care for pregnant women at risk for preterm birth. Recent studies have suggested weekly courses of antenatal corticosteroids result in improvement in the acute neonatal condition but have not supported long-term benefit. With greater understanding of the beneficial actions of corticosteroids on the fetal lung, the role for this therapy may expand. In addition to increased surfactant production and secretion, corticosteroids facilitate clearance of fetal lung fluid, as well as other maturational effects. Thus, antenatal corticosteroids may prove valuable in the late preterm period and before elective cesarean delivery at term.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hamilton B.E.
        • Martin J.A.
        • Ventura S.J.
        Births: preliminary data for 2005.
        Natl Vital Stat Rep. 2006; 55: 1-18
        • Behrman R.E.
        • Butler A.S.
        Preterm birth: causes, consequences, and prevention.
        National Academies Press, Washington, DC2007
        • Davidoff M.J.
        • Dias T.
        • Damus K.
        • et al.
        Changes in the gestational age distribution among US singleton births: impact on rates of late preterm birth, 1992 to 2002.
        Semin Perinat. 2006; 30: 8-15
        • United States Committee on Health Education Labor and Pensions
        Prematurity research expansion and education for mother who deliver infants early act or the PREEMIE Act.
        US GPO, Washington, DC2006
        • Liggins G.C.
        Premature delivery of foetal lambs infused with glucocorticoids.
        J Endocrinol. 1969; 45: 515-523
        • Liggins G.C.
        • Howie R.N.
        A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
        Pediatrics. 1970; 50: 515-525
        • Villee C.A.
        • Villee D.B.
        • Zuckerman J.
        Respiratory distress syndrome.
        Academic Press, New York1973
        • Leviton L.C.
        • Baker S.
        • Hassol A.
        • Goldenberg R.L.
        An exploration of opinion and practice patterns affecting low use of antenatal corticosteroids.
        Am J Obstet Gynecol. 1995; 173: 312-316
        • Bronstein J.M.
        • Goldenberg R.L.
        Practice variation in the use of corticosteroids: a comparison of eight data sets.
        Am J Obstet Gynecol. 1995; 173: 296-298
      1. NIH Consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes.
        JAMA. 1995; 273: 413-418
        • Crowley P.
        • Chalmers I.
        • Keirse M.J.
        The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials.
        BJOG. 1990; 97: 11-25
      2. ACOG committee opinion.
        Int J Gynaecol Obstet. 1995; 48: 340-342
        • Leviton L.C.
        • Goldenberg R.L.
        • Baker C.S.
        • et al.
        Methods to encourage the use of antenatal corticosteroid therapy for fetal maturation: a randomized controlled trial.
        JAMA. 1999; 218: 46-52
        • Bolt R.J.
        • van Weissenbruch M.M.
        • Lafeber H.N.
        • Delemarre-van de Waal H.A.
        Glucocorticoids and lung development in the fetus and preterm infant.
        Pediatr Pulmonol. 2001; 32: 76-91
        • Bland R.D.
        Lung epithelial ion transport and fluid movement during the perinatal period.
        Am K Physiol. 1990; 259: L30-L37
        • O'Brodovich H.
        Epithelial ion transport in the fetal and perinatal lung.
        Am J Physiol. 1991; 261: C555-C564
        • O'Brodovich H.
        • Canessa C.
        • Ueda J.
        Expression of the epithelial Na+ channel in the developing rat lung.
        Am J Physiol. 1993; 265: C491-C496
        • O'Brodovich H.M.
        Immature epithelial Na+ channel expression is one of the pathogenetic mechanisms leading to human neonatal respiratory distress syndrome.
        Proc Assoc Am Physicians. 1996; 108: 345-355
        • Ballard P.L.
        • Ballard R.A.
        Scientific basis and therapeutic regimens for use of antenatal glucocorticoids.
        Am J Obstet Gynecol. 1995; 173: 254-262
        • Schmid W.
        • Cole T.J.
        • Blendy J.A.
        • Schutz G.
        Molecular genetic analysis of glucocorticoid signalling in development.
        J Steroid Biochem Mol Biol. 1995; 53: 33-35
        • Roberts J.M.
        • Jacobs M.M.
        • Cheng J.B.
        • Barnes P.J.
        • O'Brien A.T.
        • Ballard P.J.
        Fetal pulmonary beta-adrenergic receptors: characterization in the human and in vitro modulation by glucocorticoids in the rabbit.
        Pediatr Pulmonol. 1985; 1: S69-S76
        • Ewing C.K.
        • Duffy D.M.
        • Roberts J.M.
        Characterization of the beta-adrenergic receptor in isolated human fetal lung type II cells.
        Pediatr Res. 1992; 32: 350-355
        • Smith D.E.
        • Otulakowski G.
        • Yeger H.
        • Post M.
        • Cutz E.
        • O'Brodovich H.M.
        Epithelial Na(+) channel (ENaC) expression in the developing normal and abnormal human perinatal lung.
        Am J Respir Crit Care Med. 2000; 161: 3122-3131
        • Venkatesh V.C.
        • Katzberg H.D.
        Glucocorticoid regulation of epithelial sodium channel genes in human fetal lung.
        Am J Physiol. 1997; 273: L227-L233
        • Jobe A.H.
        • Soll R.F.
        Choice and dose of corticosteroid for antenatal treatments.
        Am J Obstet Gynecol. 2004; 190: 878-881
        • Baud O.
        • Foix-L'Helias L.
        • Kaminski M.
        • et al.
        Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants.
        N Engl J Med. 1999; 341: 1190-1196
        • Lee B.H.
        • Stoll B.J.
        • McDonald S.A.
        • Higgins R.D.
        Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone.
        Pediatrics. 2006; 117: 1503-1510
        • Crowley P.A.
        Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994.
        Am J Obstet Gynecol. 1995; 173: 322-335
        • Feldman D.M.
        • Carbone J.
        • Belden L.
        • Borgida A.F.
        • Herson V.
        Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates.
        Am J Obstet Gynecol. 2007; 197 (284e1-4)
        • Elimian A.
        • Garry D.
        • Figueroa R.
        • Spitzer A.
        • Wiencek V.
        • Quirk J.G.
        Antenatal betamethasone compared with dexamethasone (betacode trial): a randomized controlled trial.
        Obstet Gynecol. 2007; 110: 26-30
        • Roberts D.
        • Dalziel S.
        Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
        Cochrane Database Syst Rev. 2006; 3 (CD004454)
        • Hayes E.J.
        • Paul D.A.
        • Stahl
        • et al.
        Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation.
        Obstet Gynecol. 2008; 111: 921-926
        • Tyson J.E.
        • Parikh N.A.
        • Langer J.
        • Green C.
        • Higgins R.D.
        Intensive care for extreme prematurity-moving beyond gestational age.
        N Engl J Med. 2008; 358: 1672-1681
        • Vermillion S.T.
        • Soper D.E.
        • Newman R.B.
        Is betamethasone effective longer than 7 days after treatment?.
        Obstet Gynecol. 2001; 97: 491-493
        • Peaceman A.M.
        • Bajaj K.
        • Kumar P.
        • Grobman W.A.
        The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes.
        Am J Obstet Gynecol. 2005; 193: 1165-1169
        • Sehdev H.M.
        • Abbasi S.
        • Robertson P.
        • et al.
        The effects of the time interval from antenatal corticosteroid exposure to delivery on neonatal outcome of very low birth weight infants.
        Am J Obstet Gynecol. 2004; 191: 1409-1413
        • Vidaeff A.C.
        • Ramin S.M.
        • Gilstrap 3rd, L.C.
        • Alcorn J.L.
        Characterization of corticosteroid redosing in an in vitro cell line model.
        Am J Obstet Gynecol. 2004; 191: 1403-1408
        • Ring A.M.
        • Garland J.S.
        • Stafiel B.R.
        • Carr M.H.
        • Peckman G.S.
        • Pircon R.A.
        The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study.
        Am J Obstet Gynecol. 2007; 196: 457.e1-457.e6
        • Modi N.
        • Lewis H.
        • Al-Naqeeb N.
        • Ajayi-Obe M.
        • Dore C.J.
        • Rutherford M.
        The effects of repeated antenatal glucocorticoid therapy on the developing brain.
        Pediatr Res. 2001; 50: 581-585
        • McLaughlin K.J.
        • Crowther C.A.
        • Vigneswaran P.
        • Hancock E.
        • Willson K.
        Who remains undelivered more than seven days after a single course of prenatal corticosteroids and gives birth at less than 34 weeks?.
        Aust N K J Obstet Gynaecol. 2002; 42: 353-357
        • Planer B.
        Antenatal corticosteroid (ANCS) use in preterm labor in the USA.
        Pediatr Res. 1996; 39: 110A
        • Quinlivan J.A.
        • Evans S.F.
        • Dunlop S.A.
        • Beazley L.D.
        • Newnham J.P.
        Use of corticosteroids by Australian obstetricians--a survey of clinical practice.
        Aust N Z J Obstet Gynaecol. 1998; 38: 1-7
        • Brocklehurst P.
        • Gates S.
        • McKenzie-McHarg K.
        • Alfirevic Z.
        • Chamberlain G.
        Are we prescribing multiple courses of antenatal corticosteroids?.
        BJOG. 1999; 106: 977-979
      3. NIH consensus development conference statement.
        Obstet Gynecol. 2001; 98: 144-150
        • Guinn D.A.
        • Atkinson M.W.
        • Sullivan L.
        • et al.
        Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial.
        JAMA. 2001; 286: 1581-1587
        • Lawson E.E.
        Antenatal corticosteroids-too much of a good thing?.
        JAMA. 2001; 286: 1628-1630
        • Wapner R.J.
        • Sorokin Y.
        • Thom E.A.
        • et al.
        Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy.
        Am J Obstet Gynecol. 2006; 195: 633-642
        • Crowther C.A.
        • Haslam R.R.
        • Hiller J.E.
        • Doyle L.W.
        • Robinson J.S.
        Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomized controlled trial.
        Lancet. 2006; 367: 1913-1919
        • Murphy K.
        • MACS collaborative group
        Multiple courses of antenatal corticosteroids for preterm birth study.
        Am J Obstet Gynecol. 2007; 197: S2
        • Crowther C.A.
        • Harding J.E.
        Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease.
        Cochrane Database Syst Rev. 2007; 3 (CD003935)
        • Aghajafari F.
        • Murphy K.
        • Ohlsson A.
        • Amankwah K.
        • Matthews S.
        • Hannah M.E.
        Multiple versus single courses of antenatal corticosteroids for preterm birth: a pilot study.
        J Obstet Gynaecol Can. 2002; 24: 321-329
        • McEvoy C.
        • Bowling S.
        • Williamson R.
        • et al.
        The effect of a single remote course versus weekly courses of antenatal corticosteroids on functional residual capacity in preterm infants: a randomized controlled trial.
        Pediatrics. 2002; 110: 280-284
        • Crowther C.A.
        • Doyle L.W.
        • Haslam R.R.
        • Hiller J.E.
        • Harding J.E.
        • Robinson J.S.
        Outcomes at 2 years of age after repeat doses of antenatal corticosteroids.
        N Engl J Med. 2007; 357: 1179-1189
        • Wapner R.J.
        • Sorokin Y.
        • Mele L.
        • et al.
        Long-term outcomes after repeat doses of antenatal corticosteroids.
        N Engl J Med. 2007; 357: 1190-1198
        • Dalziel S.R.
        • Liang A.
        • Parag V.
        • Rodgers A.
        • Harding J.E.
        Blood pressure at 6 years of age after prenatal exposure to betamethasone: follow-up results of a randomized, controlled trial.
        Pediatrics. 2004; 114: e373-e377
        • Dalziel S.R.
        • Walker N.K.
        • Parag V.
        • et al.
        Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomized controlled trial.
        Lancet. 2005; 365: 1856-1862
        • Caughey A.B.
        • Parer J.T.
        Recommendations for repeat courses of antenatal corticosteroids: a decision analysis.
        Am J Obstet Gynecol. 2002; 186: 1221-1226
        • Vermillion S.T.
        • Bland M.L.
        • Soper D.E.
        Effectiveness of a rescue dose of antenatal betamethasone after an initial single course.
        Am J Obstet Gynecol. 2001; 185: 1086-1089
        • Peltoniemi O.M.
        • Kari M.A.
        • Tammela O.
        • et al.
        Randomized trial of a single repeat dose of prenatal betamethasone treatment in imminent preterm birth.
        Pediatrics. 2007; 119: 290-298
        • Boggess K.A.
        • Bailit J.L.
        • Singer M.E.
        • Parisi V.M.
        • Mercer B.M.
        Projected benefits of universal or scheduled antepartum corticosteroids to prevent neonatal morbidity: a decision analysis.
        Am J Obstet Gynecol. 2005; 193: 1415-1423
        • Hansen A.K.
        • Wisborg K.
        • Uldbjerg N.
        • Henriksen T.B.
        Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study.
        BMJ. 2008; 336: 85-87
        • Stutchfield P.
        • Whitaker R.
        • Russell I.
        Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomized trial.
        BMJ. 2005; 331: 662
        • Sinclair J.C.
        Meta-analysis of randomized controlled trials of antenatal corticosteroid for the prevention of respiratory distress syndrome: discussion.
        Am J Obstet Gynecol. 1995; 173: 335-344
        • Dudell G.G.
        • Jain L.
        Hypoxic respiratory failure in the late preterm infant.
        Clin Perinat. 2006; 33: 803-830
        • Angus D.C.
        • Linde-Zwirble W.T.
        • Clermont G.
        • Griffin M.F.
        • Clark R.H.
        Epidemiology of neonatal respiratory failure in the United States: projections from California and New York.
        Am J Respir Crit Care Med. 2001; 164: 1154-1160
        • Jain L.
        • Chen X.J.
        • Ramosevac S.
        • Brown L.A.
        • Eaton D.C.
        Expression of highly selective sodium channels in alveolar type II cells is determined by culture conditions.
        Am J Physiol Lung Cell Mol Physiol. 2001; 280: L646-L658